similispharma@gmail.com

Ares Capital Cut Dividend Impacts Australian Entrepreneurship

As the Australian entrepreneurial landscape continues to experience turbulence, investors and business leaders are keeping a watchful eye on the global economy’s shifting tides. In this climate, the sudden decline of Ares Capital’s (ARCC) share price has sparked concerns that the company might be forced to cut its dividend. The 25% slump in the stock’s […]

Ares Capital Cut Dividend Impacts Australian Entrepreneurship Read More »

Mistral Raises $830M For AI Data Center Shaping India Startups

In the rapidly evolving landscape of artificial intelligence and data centers, a monumental shift is underway in the Indian startup ecosystem. The recent announcement of Mistral raising $830 million in debt to build an AI data center in Paris, utilizing Nvidia chips, has sent shockwaves across the nation. This significant development not only underscores the

Mistral Raises $830M For AI Data Center Shaping India Startups Read More »

Goldman Sachs Initiates Qualcomm Neutral Shaping Canada Startups

The tech sector has been abuzz with news that Goldman Sachs has initiated coverage of Qualcomm, the world-renowned American multinational semiconductor and telecommunications equipment company. The investment giant has set a price target of $135 for the company’s shares, pegging it at a neutral rating. While some may view this move as a mere update

Goldman Sachs Initiates Qualcomm Neutral Shaping Canada Startups Read More »

Bristol Gate Sells Zoetis Shaping India Investments

The recent sell-off of Zoetis (ZTS) by Bristol Gate Capital Partners has sent shockwaves through the Indian investment community. For those unfamiliar, Bristol Gate Capital Partners is a prominent American investment firm known for its astute market analysis and portfolio management expertise. The decision to sell Zoetis, one of the world’s leading animal health companies,

Bristol Gate Sells Zoetis Shaping India Investments Read More »